However, JARID1B can act in concert with LSD1, to remove three H3K4 methylation marks from the C-C Motif Chemokine Ligand 14 (CCL14) promoter, resulting in inhibition of chemokine-mediated migration, angiogenesis and breast cancer metastasis [99]. This evidence concerns the gene CCL14 and breast carcinoma.